Literature DB >> 15245435

Autocrine catecholamine biosynthesis and the beta-adrenoceptor signal promote pigmentation in human epidermal melanocytes.

Johanna M Gillbro1, Lee K Marles, Nigel A Hibberts, Karin U Schallreuter.   

Abstract

Earlier it has been shown that human proliferating/undifferentiated basal keratinocytes hold the full capacity for autocrine catecholamine synthesis/degradation and express beta2-adrenoceptors (beta2-AR). In this report, we show that human melanocytes also express all of the mRNA and enzymes for autocrine synthesis of norepinephrine but fail to produce epinephrine. So far, it was established that human melanocytes express alpha1-AR which are induced by norepinephrine yielding the inosine triphosphate diacylglycerol signal. The presence of catecholamine synthesis and the beta2-AR signal escaped definition at that time. Using RT-PCR, immunofluorescence and radioligand binding with the beta2-AR antagonist (-)-[3H]CGP 12177, we show here that human melanocytes express functional beta2-AR (4230 receptors per cell) with a Bmax at 129.3 and a KD of 3.19 nM but lack beta1-AR expression. beta2-AR stimulation with epinephrine 10(-6) M and salbutamol 10(-6)-10(-5) M yielded a strong cyclic adenosine monophospate (cAMP) response in association with upregulated melanin production. Taken together these results indicate that the biosynthesis and release of epinephrine (10(-6) M) by surrounding keratinocytes can provide the cAMP response leading to melanogenesis in melanocytes via the beta2-AR signal. Moreover, the discovery of this catecholaminergic cAMP response in melanocytes adds a new source for this important second messenger in melanogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245435     DOI: 10.1111/j.0022-202X.2004.23210.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  31 in total

1.  Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells.

Authors:  Lori L Stohl; Julie B Zang; Wanhong Ding; Michela Manni; Xi K Zhou; Richard D Granstein
Journal:  Cytokine       Date:  2013-09-08       Impact factor: 3.861

Review 2.  Neuroendocrine system of the skin.

Authors:  Andrzej Slominski
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

Review 3.  Beta adrenergic receptors in keratinocytes.

Authors:  Raja K Sivamani; Susanne T Lam; R Rivkah Isseroff
Journal:  Dermatol Clin       Date:  2007-10       Impact factor: 3.478

4.  Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.

Authors:  Bing Luan; Zhenning Zhang; Yalan Wu; Jiuhong Kang; Gang Pei
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

Review 5.  Prevention of Photocarcinogenesis by Agonists of 5-HT1A and Antagonists of 5-HT2A Receptors.

Authors:  Ana Catarina Menezes; Sara Raposo; Sandra Simões; Helena Ribeiro; Helena Oliveira; Andreia Ascenso
Journal:  Mol Neurobiol       Date:  2015-01-15       Impact factor: 5.590

Review 6.  Stress-related skin disorders.

Authors:  Alex Alexopoulos; George P Chrousos
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

7.  α2-Adrenoceptor agonist induces peripheral antinociception via the endocannabinoid system.

Authors:  Thiago Roberto Lima Romero; Marina Gomes Miranda E Castor; Cosimo Parrella; Fabiana Piscitelli; Vincenzo Di Marzo; Igor Dimitri Gama Duarte
Journal:  Pharmacol Rep       Date:  2020-01-10       Impact factor: 3.024

Review 8.  Hair follicle pigmentation.

Authors:  Andrzej Slominski; Jacobo Wortsman; Przemyslaw M Plonka; Karin U Schallreuter; Ralf Paus; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

Review 9.  The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Authors:  Roberta Colucci; Silvia Moretti
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-23       Impact factor: 4.553

10.  Inhibition of human melanoma growth by a non-cardioselective β-blocker.

Authors:  Ludovic J Wrobel; Frederique Anne Le Gal
Journal:  J Invest Dermatol       Date:  2014-09-01       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.